Xconomy National

Archives

by in
Entry Author Date Location
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News Bruce V. Bigelow 11/10/11 San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News Bruce V. Bigelow 08/04/11 San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News Bruce V. Bigelow 07/28/11 San Diego
A San Diego Sampler from the War on Diabetes Bruce V. Bigelow 06/24/11 San Diego
Inception 1 Raises $5M, VCs Pessimistic About U.S. Biotech Funding, EU Approves Amylin’s Once-a-Week Diabetes Drug, & More San Diego Life Sciences News Bruce V. Bigelow 06/23/11 San Diego
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News Bruce V. Bigelow 06/09/11 San Diego
Amylin Gets TRO Against Lilly Bruce V. Bigelow 05/26/11 San Diego
Shire Pays $750M for Advanced BioHealing, Amylin Sues Lilly, Pacira CEO Describes His Most Difficult Task, & More San Diego Life Sciences News Bruce V. Bigelow 05/19/11 San Diego
Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug Luke Timmerman 05/16/11 San Diego
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News Erin Kutz 11/19/10 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News Erin Kutz 10/22/10 Boston
Sequenom Restarts Down Syndrome Test, Cytori Upbeat About Cardiac Study, Pathway Genomics Mass Markets Genome Tests, & More San Diego Life Sciences News Denise Gellene 05/13/10 San Diego
Novartis Buys Alnylam Shares, Xconomy Holds First Ever Health IT Forum, Vertex Alumni Spread Throughout Life Sciences Sector, & More Boston-Area Life Sciences News Erin Kutz 04/30/10 Boston
Warner Bros. Acquires Turbine, Athenahealth Taps IBM, Alkermes Reveals Diabetes Drug Royalty, & More Boston-Area Deals News Erin Kutz 04/28/10 Boston
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug Luke Timmerman 09/29/09 San Diego
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News Bruce V. Bigelow 06/11/09 San Diego
Amylin Founder Ted Greene, In Exclusive Interview, Upbeat About Outcome of Proxy Battle Bruce V. Bigelow 06/02/09 San Diego
Vical Developing Vaccine for Swine Flu, Acadia’s Stock Almost Doubles on Biovail Deal, Qualcomm Launches Business Plan Contest, & Other San Diego BizTech News Bruce V. Bigelow 05/11/09 San Diego
Diabetes Drug Application May Be New Factor in Amylin Proxy Battle Juha-Pekka Tikka 05/05/09 San Diego
Amylin Braces for Proxy Battle Amid Flurry of Filings Bruce V. Bigelow 04/09/09 San Diego
Amylin Shares Soar as Diabetes Drug Catches a Break From FDA Luke Timmerman 12/11/08 San Diego
Biotech Survival Index: Cash Woes Creeping Up on San Diego Life Sciences Companies Luke Timmerman 11/18/08 San Diego
Aileron Develops New Class of Drugs To Go Where None Could Before Luke Timmerman 11/07/08 Boston
Amylin, Alkermes Shares Plunge On Possible FDA Delays Luke Timmerman 11/04/08 San Diego
Amylin Shareholder Floats Idea of Selling Company Luke Timmerman 11/04/08 San Diego
Amylin Gets $125M from Eli Lilly To Make Once-Weekly Diabetes Drug Luke Timmerman 10/21/08 San Diego
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.